Ian F. Smith

About

Ian F. Smith is a biotechnology executive and board leader focused on rare disease and broader biopharma company building. He is the Chief Executive Officer and a director of Stoke Therapeutics, and previously served as executive vice president, chief operating officer, and chief financial officer of Vertex Pharmaceuticals between 2001 and 2019. He also serves in board leadership roles at Solid Biosciences and Rivus Pharmaceuticals and sits on multiple biotech company boards.

Areas of interest